The effects of a widely used antitumour drug, cisplatin, on freshly isolated porcine proximal tubular cells (PPTC) in suspension were investigated. Incubation of the PPTC with 5-500μM cisplatin resulted in a decrease in mitochondrial membrane potential (MMP) and in cell death. In addition, the formation of reactive oxygen species (ROS) was observed within 20 minutes. Prevention of ROS formation with the antioxidants diphenyl-p-phenylene-diamine (DPPD) or desferrioxamine had no effect on the cisplatin-induced effects on MMP and cell death, implying that cisplatin-induced ROS formation is not a cause of cell death. In order to investigate whether the ROS formation was related to mitochondrial damage, we determined the effects of cisplatin on the enzymatic activities of NADP:ubiquinone reductase (Complex I) and succinate:ubiquinone reductase (Complex II) of the respiratory chain. Exposure of the PPTC to cisplatin resulted in a time-dependent and dose-dependent inhibition of the activities of both Complex I and Complex II. The inhibition of these activities and the depletion of ATP could not be prevented by the antioxidants, indicating that these effects are not a consequence of ROS formation. We propose that damage to the mitochondria could be a key event in cisplatin-induced cell death.
BorchR.F. (1987). The platinum antitumour drugs. In Metabolism and Action of Anticancer Drugs (ed. PowisG., ProughR.A.), pp. 163–193. London: Taylor & Francis.
2.
DoybanD.C., LeviJ., JacobsC., KosekJ., and WeinerM.W. (1980). Mechanisms of cisplatin-induced nephrotoxicity. II. Morphologic observations.Journal of Pharmacology and Experimental Therapeutics213, 551–556.
3.
Gonzalez-VitaleJ.C., HayesD.M., CvitkovicE., & SternbergS.S. (1977). The renal pathology in clinical trials of cis-platinum-diamminedichloride.Cancer39, 1362–1371.
4.
HannemannJ., and BaumannK. (1988). Cisplatin-induced lipid peroxidation and decrease of gluconeogenesis in rat kidney cortex: different effects of antioxidants and radical scavengers.Toxicology51, 119–132.
5.
VermeulenN.P.E., and BaldewG.S. (1992). The role of lipid peroxidation in the nephrotoxicity of cisplatin.Biochemical Pharmacology44, 1193–1199.
6.
ZhangJ.G., ZhongL.F., ZhangM., MaX.L., XiaY.X., and LindupW.E. (1994). Amelioration of cisplatin toxicity in rat renal cortical slices by dithiothreitol in vitro.Human and Experimental Toxicology13, 89–93.
7.
ZhangJ.G., and LindupW.E. (1994). Effects of procaine and two of its metabolites on cisplatin-induced kidney injury in vitro: mitochondrial aspects.Toxicology in Vitro8, 477–481.
8.
SugiharaK., NakanoS., KodaM., TanakaK., FukuishiN., and GembaM. (1987). Stimulatory effects of cisplatin on production of lipid peroxidation in renal tissues.Japanese Journal of Pharmacology43, 247–252.
9.
KameyamaT., and GembaM. (1991). The iron chelator deferoxamine prevents cisplatin-induced lipid peroxidation in rat kidney cortical slices.Japanese Journal of Pharmacology57, 259–262.
10.
ZhangJ.G., and LindupW.E. (1994). Cisplatin nephrotoxicity: decreases in mitochondrial protein sulphydryl concentration and calcium uptake by mitochondria from rat renal cortical slices.Biochemical Pharmacology47, 1127–1135.
11.
GembaM., FukuishiN., and NakanoS. (1988). Effect of N-N-diphenyl-p-phenylenediamine pretreatment on urinary enzyme excretion in cisplatin nephrotoxicity in rats.Japanese Journal of Pharmacology46, 90–92.
12.
SadzukaY., ShojiT., and TakinoY. (1992). Mechanism of the increase in lipid peroxide induced by cisplatin in the kidneys of rats.Toxicology Letters62, 293–300.
13.
SadzukaY., ShojiT., and TakinoY. (1992). Effect of cisplatin on the activities of enzymes which protect against lipid peroxidation.Biochemical Pharmacology43, 1872–1875.
14.
SadzukaY., ShimizuY., and TakinoY. (1994). Role of glutathione S-transferase isoenzymes in cisplatin-induced nephrotoxicity in the rat.Toxicology Letters70, 211–222.
15.
SinghG. (1989). A possible cellular mechanism of cisplatin-induced nephrotoxicity.Toxicology58, 71–80.
16.
GembaM., NakataniE., TeramotoM., and NakanoS. (1987). Effect of cisplatin on calcium uptake by rat kidney cortical mitochondria.Toxicology Letters38, 291–297.
17.
RosenM., FigliomeniM., and SimpkinsH. (1992). The interaction of platinum antitumour drugs with mouse liver mitochondria.International Journal of Experimental Pathology73, 61–74.
18.
GembaM., and FukuishiN. (1991). Amelioration by ascorbic acid of cisplatin-induced injury in cultured renal epithelial cells. In Contributions to Nephrology, Vol. 95, Cellular and Molecular Biology of the Kidney (ed. KoideH., EndouH., KurokawaK.), pp. 138–142. Basel, Switzerland: Karger.
19.
KameyamaY., and GembaM. (1991). Cisplatin-induced injury to calcium uptake by mitochondria in glutathione-depleted slices of rat kidney cortex.Japanese Journal of Pharmacology55, 174–176.
20.
KruideringM., MaasdamD.H., PrinsF.A., de HeerE., MulderG.J., and NagelkerkeJ.F. (1994). Evaluation of nephrotoxicity in vitro using a suspension of highly purified porcine proximal tubular cells and characterization of the cells in primary culture.Experimental Nephrology2, 334–344.
21.
ShanX., JonesD.P., HashmiM., and AndersM.W. (1993). Selective depletion of mitochondrial glutathione concentrations by (R,S)-3-hydroxy-4-pentenoate potentiates oxidative cell death.Chemical Research in Toxicology6, 75–81.
22.
KruideringM., PrinsF.A., de HeerE., MulderG.J., and NagelkerkeJ.F. (1993). Isolation and culture of proximal tubular cells from porcine kidney.ATLA21, 457–465.
23.
Van De WaterB., ZoeteweyJ.P., De BontH.J.G.M., MulderG.J., and NagelkerkeJ.F. (1993). The relationship between intracellular Ca2+ and the mitochondrial membrane potential in isolated proximal tubular cells from rat kidney exposed to the nephrotoxin 1,2–dichlorovinyl-cysteine.Biochemical Pharmacology45, 2259–2267.
24.
EstornellE., FatoR., PallotiF., and LenazG. (1993). Assay conditions for the mitochondrial NADH:coenzyme Q oxioreductase.FEBS Letters332, 127–131.
25.
LowryO.H., RosebroughN.J., FarrA.L., and RandauR.J. (1951). Protein measurement with the folin phenol reagent.Journal of Biological Chemistry193, 265–275.
26.
KimmichG.A., RandiesJ., and BrandJ.S. (1975). Assay of picomole amounts of ATP, ADP and AMP using the luciferase enzyme system.Analytical Biochemistry69, 187–206.
27.
CampbellA.B., KalmanS.M., and JacobsC. (1983). Plasma platinum levels: relationships to cisplatin dose and nephrotoxicity.Cancer Treatment Reports67, 169–172.
28.
HannemannJ., and BaumannK. (1990). Nephrotoxicity of cisplatin, carboplatin and transplatin: a comparative in vitro study.Archives of Toxicology64, 393–400.
29.
ZhangJ.G., ZhongL.F., ZhangM., and XiaY.X. (1992). Protection effects of procaine on oxidative stress and toxicities of renal cortical slices from rats caused by cisplatin in vitro.Archives of Toxicology66, 354–358.
30.
BradyH.R., ZeidelM.L., KoneB.C., GiebischG., and GullansS.R. (1993). Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.Journal of Pharmacology and Experimental Therapeutics265, 1421–1428.
31.
GordonJ.A., and GattoneV.H. (1986). Mitochondrial alterations in cisplatin-induced acute renal failure.American Journal of Physiology250, F991–F998.
32.
BradyH.R., KoneB.C., StromskiM.E., ZeidelM.L., GiebischG., and GullansS.R. (1990). Mitochondrial injury: an early event in cisplatin toxicity to renal proximal tubules.American Journal of Physiology258, F1181–F1187.
33.
McGuinnessS.J., and RyanM.P. (1994). Mechanism of cisplatin nephrotoxicity in rat renal proximal tubule suspensions.Toxicology in Vitro8, 1203–1212.
34.
BradyH.R., ZeidelM.L., KoneB.C., GiebischG., and GullansS.R. (1993). Differential actions of cisplatin on renal proximal tubule and inner medullary collecting duct cells.Journal of Pharmacology and Experimental Therapeutics265, 1421–1426.
